Katarzyna Miękus

Has grant

Jagiellonian University

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Cancer Biology Cancer Biology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Regulacja procesu przejścia epitelialno-mezenchymalnego i oporności na stosowane terapie przeciwnowotworowe przez białko MCPIP1

Open Date: 2018-05-17

Close Date: 2023-05-16

Grant: Close

Regulation of the epithelial-mesenchymal transition process and resistance to the used anti-cancer therapies by the MCPIP1 protein

Open Date: 2018-05-01

Close Date: 2023-05-01

Grant: Close

Rola białka MCPIP1 w procesach wzrostu, progresji i unaczynienia jasnokomórkowego raka nerki.

Open Date: 2016-06-23

Close Date: 2020-06-22

Grant: Close

The role of MCPIP1 protein in the processes of growth, progression and vascularization of clear cell renal cancer

Open Date: 2016-06-01

Close Date: 2020-06-01

Grant: Close

Analiza molekularna udziału białka MCPIP1 w hamowaniu przejścia epitelialno-mezenchymalnego

Open Date: 2016-01-01

Close Date: 2017-12-31

Articles (8)

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Jolanta Jura

Jagiellonian University

POLAND

View details

Jerzy Kotlinowski

Jagiellonian University

POLAND

View details

Judyta Górka

Jagiellonian University

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Katarzyna Miękus

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (8)

Hepatic MCPIP1 protein levels are reduced in NAFLD patients and are predominantly expressed in cholangiocytes and liver endothelium

Resistance to tyrosine kinase inhibitors promotes renal cancer progression through MCPIP1 tumor-suppressor downregulation and c-Met activation.

MCPIP1 regulates focal adhesion kinase and Rho GTPase-dependent migration in clear cell renal cell carcinoma.

Deletion of Mcpip1 in Mcpip1<sup>fl/fl</sup>Alb<sup>Cre</sup> mice recapitulates the phenotype of human primary biliary cholangitis.

Fatty Acids and a High-Fat Diet Induce Epithelial–Mesenchymal Transition by Activating TGFβ and β-Catenin in Liver Cells

MCPIP1 inhibits Wnt/β-catenin signaling pathway activity and modulates epithelial-mesenchymal transition during clear cell renal cell carcinoma progression by targeting miRNAs.

New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis.

The anti-inflammatory protein MCPIP1 inhibits the development of ccRCC by maintaining high levels of tumour suppressors.

Collaborators (3)

Jolanta Jura

Jerzy Kotlinowski

Judyta Górka

Make your next move.